Paliperidone-loaded mucoadhesive microemulsion in treatment of schizophrenia: Formulation consideration

Journal of Pharmaceutical Innovation

Volumn 8, Issue 3, 2013, Pages 195-204

  Patel, Rashmin B ^a   Patel, Mrunali R ^b   Bhatt, Kashayap K ^b   Patel, Bharat G ^c  

^a AR Patel and GH Patel Institute of Pharmacy   (India)

^b Indukaka Ipcowala College of Pharmacy   (India)

^c CHAROTAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Intranasal delivery; Microemulsion; Paliperidone; Schizophrenia

Indexed keywords

CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; LABRASOL; METHANOL; MYRISTIC ACID ISOPROPYL ESTER; OCTANOIN; OLEIC ACID; PALIPERIDONE; POLYCARBOPHIL; POLYGLYCERYL OLEATE; POLYMER; POLYSORBATE 80; POTASSIUM DIHYDROGEN PHOSPHATE; PROPYLENE GLYCOL; PROPYLENE GLYCOL MONOLAURATE; UNCLASSIFIED DRUG;

ARTICLE; DIFFUSION COEFFICIENT; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG STABILITY; IN VITRO STUDY; MICROEMULSION; MUCOADHESION; PARTICLE SIZE; PRIORITY JOURNAL; SCHIZOPHRENIA; ZETA POTENTIAL;

EID: 84890426944     PISSN: 18725120     EISSN: 19398042     Source Type: Journal    
DOI: 10.1007/s12247-013-9160-3     Document Type: Article

References (25)

1. Canuso CM et al. Paliperidone extended-release tablets in schizophrenia patients previously treated with risperidone. Int Clin Psychopharmacol. 2008;23:209-15.
2. Zacher JL. Paliperidone extended-release tablets (Invega). Psychopharmacol Rev. 2007;42:51-8.
3. Nasrallah HA et al. Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psychiatr Serv. 2005;56:273-82.
4. Thorne RG et al. Delivery of neurotropic factor to the central nervous system: pharmacokinetic consideration. Clin Pharmacokinet. 2001;40:907-46.
5. Born J et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci. 2002;5:514-6.
6. Illum L. Nasal drug delivery: new development strategies. Drug Discov Today. 2002;7:1184-9.
7. Elshafeey AH et al. Intranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbits. AAPS PharmSciTech. 2009;10:361-4.
8. Vyas TK et al. Intranasal mucoadhesive microemulsion of zolmitriptan: preliminary studies on brain targeting. J Drug Target. 2005;13:317-24.
9. Vyas TK et al. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting. J Pharm Sci. 2006;95:570-80.
10. Li L et al. Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam. Int J Pharm. 2002;237:77-85.
11. Zhang Q et al. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm. 2004;275:85-96.
12. Kaur P et al. Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits. Int J Pharm. 2008;364:27-35.
13. Jogani VV et al. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting. Alzheimer Dis Assoc Disord. 2008;22:116-24.
14. Kumar M et al. Formulation and characterization of nanoemulsion based drug delivery system of risperidone. Drug Dev Ind Pharm. 2009;35:387-95.
15. Kumar M et al. Mucoadhesive nanoemulsion-based intranasal drug delivery system of olanzapine for brain targeting. J Brain Target. 2008;16:806-14.
16. Barakat NS et al. Carbamazepine uptake into rat brain following intra-olfactory transport. J Pharm Pharmacol. 2006;58:63-72.
17. Patel MR et al. Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole. AAPS PharmSciTech. 2009;10:917-23.
18. Patel MR et al. Investigating effect of microemulsion components: in vitro permeation of ketoconazole. Pharma Dev Technol. 2011;16:250-8.
19. Patel RB et al. HPTLC method development and validation: quantification of paliperidone in formulations and in vitro release study. Anal Methods. 2010;2:525-31.
20. Nakamura F et al. In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int J Pharm. 1996;134:173-81.
21. Pierre MB et al. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy. Pharm Res. 2006;23:360-6.
22. Wu H et al. From nose to brain: understanding transport capacity and transport rate of drugs. Expert Opin Drug Deliv. 2008;5:1159-68.
23. Gao Y et al. The permeation of nalmefene hydrochloride across different regions of ovine nasal mucosa. Chem Pharm Bull. 2006;5412:1722-4.
24. Sharma G et al. Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies. AAPS PharmSciTech. 2009;10:1321-30.
25. Karasulu E et al. Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers. Drug Deliv. 2008;15:219-25.